Grant: CIHR Fellowship
Direct Payment
$100,000.00
Impact of smoking during pregnancy on placental function in relation to preeclampsia
EF 2015-16
Résumé
Cigarette smoking during pregnancy is toxic for the mother and her fetus, increasing greatly the perinatal morbidity. Nicotine influences the size of the placenta and increases the risk of placenta-mediated disease. Despite the efforts of research and health professional, maternal smoking during pregnancy remains a serious public health problem.
Preeclampsia is a severe pregnancy complication related to impaired placentation, which result in new onset of hypertension and proteinuria. This condition, affecting 2-8% of pregnancies, is also associated with preterm birth, intrauterine growth restriction and fetal death, and is the one of the leading cause of maternal and perinatal morbidity and mortality.
Unexpectedly, pooled data from studies showed that cigarette smoking during pregnancy has been associated with a significant reduction of preeclampsia. The relation between preeclampsia and smoking during pregnancy is unclear and the origin of the protective effect of smoking is unknown. Recently, several maternal serum biomarkers and ultrasonographic markers have been used to measure placental and endothelial function related to preeclampsia and fetal growth restriction.
For this study, we aim to evaluate the impact of smoking on placental function, placental growth and fetal growth over the three trimesters of pregnancy using new biochemical and ultrasonographic markers, and considering potential confounding and modifying factors. We will perform secondary analysis of the biggest cohort in the world on pregnant women: Fetal Medicine Foundation (FMF).
The results of this study will be highly important for a better understanding of the origins of placental disease and on the impact of environmental effect such as smoking. Since early-onset preeclampsia is one the major adverse pregnancy outcome, this study will contribute to the advancement of knowledge with potential great impact on mother and child health.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
England, United Kingdom
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
338573
Name
Roberge Stéphanie
Region
England
Country
United Kingdom
Orgtype
Research Institution
Instname2
Population and Public Health
Theme2
Clinical
Prcname2
Fellowships - Post-PhD
Projecttitle
Impact of smoking during pregnancy on placental function in relation to preeclampsia
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Maternal And Fetal Medicine; Perinatal Epidemiology; Preeclampsia
Abstract
Cigarette smoking during pregnancy is toxic for the mother and her fetus, increasing greatly the perinatal morbidity. Nicotine influences the size of the placenta and increases the risk of placenta-mediated disease. Despite the efforts of research and health professional, maternal smoking during pregnancy remains a serious public health problem.
Preeclampsia is a severe pregnancy complication related to impaired placentation, which result in new onset of hypertension and proteinuria. This condition, affecting 2-8% of pregnancies, is also associated with preterm birth, intrauterine growth restriction and fetal death, and is the one of the leading cause of maternal and perinatal morbidity and mortality.
Unexpectedly, pooled data from studies showed that cigarette smoking during pregnancy has been associated with a significant reduction of preeclampsia. The relation between preeclampsia and smoking during pregnancy is unclear and the origin of the protective effect of smoking is unknown. Recently, several maternal serum biomarkers and ultrasonographic markers have been used to measure placental and endothelial function related to preeclampsia and fetal growth restriction.
For this study, we aim to evaluate the impact of smoking on placental function, placental growth and fetal growth over the three trimesters of pregnancy using new biochemical and ultrasonographic markers, and considering potential confounding and modifying factors. We will perform secondary analysis of the biggest cohort in the world on pregnant women: Fetal Medicine Foundation (FMF).
The results of this study will be highly important for a better understanding of the origins of placental disease and on the impact of environmental effect such as smoking. Since early-onset preeclampsia is one the major adverse pregnancy outcome, this study will contribute to the advancement of knowledge with potential great impact on mother and child health.
Competitiondate
201511
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Roberge, Stéphanie
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $100,000~ $0~